Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Cell Mol Biol (Noisy-le-grand) ; 51 Suppl: OL729-35, 2005 Sep 02.
Artigo em Inglês | MEDLINE | ID: mdl-16171572

RESUMO

A large number of chronic lung diseases such as asthma bronchiale are associated with alveolar and/or bronchial inflammation accompanied by a damage of the alveolocapillary barrier. In this process proteolytic mechanisms may play a crucial role. The aim of the present study was to assess the role of TNF-alpha on the proteolytic activity of pulmonary epithelial cells and to find possible intracellular signaling pathways which may mediate the effect of TNF-alpha. For our studies we have used the A549 human lung epithelial cell line. Plasminogen activator and metalloproteinase activity was measured using zymography. TNF-alpha induced a time and concentration dependent activation of the urokinase type plasminogen activator (u-PA) and tissue type plasminogen activator (t-PA) activity in A549 cells. This effect could be blocked completely by dexamethasone and was reduced significantly by the Rho-kinase inhibitor Y27632. Similarly, an increased activity in the culture medium of the 72 kDa MMP-2 in response to TNF-alpha could be observed as well. This could be reduced by dexamethasone and Y27632. Our results show that TNF-alpha is at least partly responsible for an increased proteolytic activity and beside corticosteroids Rho-kinase may constitute a potential target for future therapeutical approaches.


Assuntos
Células Epiteliais/metabolismo , Mediadores da Inflamação/fisiologia , Pulmão/citologia , Processamento de Proteína Pós-Traducional , Movimento Celular , Células Cultivadas , Meios de Cultivo Condicionados , Dexametasona/farmacologia , Relação Dose-Resposta a Droga , Indução Enzimática/efeitos dos fármacos , Células Epiteliais/citologia , Células Epiteliais/efeitos dos fármacos , Humanos , Mediadores da Inflamação/farmacologia , Metaloproteinase 2 da Matriz/metabolismo , Processamento de Proteína Pós-Traducional/efeitos dos fármacos , Transdução de Sinais , Frações Subcelulares , Fatores de Tempo , Ativador de Plasminogênio Tecidual , Fator de Necrose Tumoral alfa/farmacologia , Ativador de Plasminogênio Tipo Uroquinase
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA